Compile Data Set for Download or QSAR
Report error Found 37 Enz. Inhib. hit(s) with all data for entry = 12831
TargetDNA-dependent protein kinase catalytic subunit(Human)
Vertex Pharmaceuticals

US Patent
LigandPNGBDBM731587(US12269804, Compound 11)
Affinity DataKi: <1nMAssay Description:To investigate the effect of DNA-PK inhibitors on HDR gene editing rates, BECs were electroporated with spCAS9 mRNA, NAV1.7 sgRNA and NAV1.7 Non-PAM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Vertex Pharmaceuticals

US Patent
LigandPNGBDBM731586(US12269804, Compound 10)
Affinity DataKi: <1nMAssay Description:To investigate the effect of DNA-PK inhibitors on HDR gene editing rates, BECs were electroporated with spCAS9 mRNA, NAV1.7 sgRNA and NAV1.7 Non-PAM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Vertex Pharmaceuticals

US Patent
LigandPNGBDBM731569(US12269804, Compound 16)
Affinity DataKi: <1nMAssay Description:To investigate the effect of DNA-PK inhibitors on HDR gene editing rates, BECs were electroporated with spCAS9 mRNA, NAV1.7 sgRNA and NAV1.7 Non-PAM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Vertex Pharmaceuticals

US Patent
LigandPNGBDBM731585(US12269804, Compound 36)
Affinity DataKi: <1nMAssay Description:To investigate the effect of DNA-PK inhibitors on HDR gene editing rates, BECs were electroporated with spCAS9 mRNA, NAV1.7 sgRNA and NAV1.7 Non-PAM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Vertex Pharmaceuticals

US Patent
LigandPNGBDBM731568(US12269804, Compound 15)
Affinity DataKi: <1nMAssay Description:To investigate the effect of DNA-PK inhibitors on HDR gene editing rates, BECs were electroporated with spCAS9 mRNA, NAV1.7 sgRNA and NAV1.7 Non-PAM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Vertex Pharmaceuticals

US Patent
LigandPNGBDBM731584(US12269804, Compound 35)
Affinity DataKi: <1nMAssay Description:To investigate the effect of DNA-PK inhibitors on HDR gene editing rates, BECs were electroporated with spCAS9 mRNA, NAV1.7 sgRNA and NAV1.7 Non-PAM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Vertex Pharmaceuticals

US Patent
LigandPNGBDBM731567(US12269804, Compound 14)
Affinity DataKi: <1nMAssay Description:To investigate the effect of DNA-PK inhibitors on HDR gene editing rates, BECs were electroporated with spCAS9 mRNA, NAV1.7 sgRNA and NAV1.7 Non-PAM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Vertex Pharmaceuticals

US Patent
LigandPNGBDBM731583(US12269804, Compound 34)
Affinity DataKi: <1nMAssay Description:To investigate the effect of DNA-PK inhibitors on HDR gene editing rates, BECs were electroporated with spCAS9 mRNA, NAV1.7 sgRNA and NAV1.7 Non-PAM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Vertex Pharmaceuticals

US Patent
LigandPNGBDBM731582(US12269804, Compound 33)
Affinity DataKi: <1nMAssay Description:To investigate the effect of DNA-PK inhibitors on HDR gene editing rates, BECs were electroporated with spCAS9 mRNA, NAV1.7 sgRNA and NAV1.7 Non-PAM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Vertex Pharmaceuticals

US Patent
LigandPNGBDBM731560(US12269804, Compound 5)
Affinity DataKi: <1nMAssay Description:To investigate the effect of DNA-PK inhibitors on HDR gene editing rates, BECs were electroporated with spCAS9 mRNA, NAV1.7 sgRNA and NAV1.7 Non-PAM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Vertex Pharmaceuticals

US Patent
LigandPNGBDBM731590(US12269804, Compound 27)
Affinity DataKi: <1nMAssay Description:To investigate the effect of DNA-PK inhibitors on HDR gene editing rates, BECs were electroporated with spCAS9 mRNA, NAV1.7 sgRNA and NAV1.7 Non-PAM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Vertex Pharmaceuticals

US Patent
LigandPNGBDBM731588(US12269804, Compound 12)
Affinity DataKi: <1nMAssay Description:To investigate the effect of DNA-PK inhibitors on HDR gene editing rates, BECs were electroporated with spCAS9 mRNA, NAV1.7 sgRNA and NAV1.7 Non-PAM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Vertex Pharmaceuticals

US Patent
LigandPNGBDBM731578(US12269804, Compound 28)
Affinity DataKi:  2nMAssay Description:To investigate the effect of DNA-PK inhibitors on HDR gene editing rates, BECs were electroporated with spCAS9 mRNA, NAV1.7 sgRNA and NAV1.7 Non-PAM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Vertex Pharmaceuticals

US Patent
LigandPNGBDBM731593(US12269804, Compound 38)
Affinity DataKi:  2nMAssay Description:To investigate the effect of DNA-PK inhibitors on HDR gene editing rates, BECs were electroporated with spCAS9 mRNA, NAV1.7 sgRNA and NAV1.7 Non-PAM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Vertex Pharmaceuticals

US Patent
LigandPNGBDBM731591(US12269804, Compound 29)
Affinity DataKi:  2nMAssay Description:To investigate the effect of DNA-PK inhibitors on HDR gene editing rates, BECs were electroporated with spCAS9 mRNA, NAV1.7 sgRNA and NAV1.7 Non-PAM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Vertex Pharmaceuticals

US Patent
LigandPNGBDBM731557(US12269804, Compound 2)
Affinity DataKi:  2nMAssay Description:To investigate the effect of DNA-PK inhibitors on HDR gene editing rates, BECs were electroporated with spCAS9 mRNA, NAV1.7 sgRNA and NAV1.7 Non-PAM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Vertex Pharmaceuticals

US Patent
LigandPNGBDBM731589(US12269804, Compound 26)
Affinity DataKi:  2nMAssay Description:To investigate the effect of DNA-PK inhibitors on HDR gene editing rates, BECs were electroporated with spCAS9 mRNA, NAV1.7 sgRNA and NAV1.7 Non-PAM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Vertex Pharmaceuticals

US Patent
LigandPNGBDBM731561(US12269804, Compound 6)
Affinity DataKi:  3nMAssay Description:To investigate the effect of DNA-PK inhibitors on HDR gene editing rates, BECs were electroporated with spCAS9 mRNA, NAV1.7 sgRNA and NAV1.7 Non-PAM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Vertex Pharmaceuticals

US Patent
LigandPNGBDBM731594(US12269804, Compound 39)
Affinity DataKi:  3nMAssay Description:To investigate the effect of DNA-PK inhibitors on HDR gene editing rates, BECs were electroporated with spCAS9 mRNA, NAV1.7 sgRNA and NAV1.7 Non-PAM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Vertex Pharmaceuticals

US Patent
LigandPNGBDBM731559(US12269804, Compound 4)
Affinity DataKi:  3nMAssay Description:To investigate the effect of DNA-PK inhibitors on HDR gene editing rates, BECs were electroporated with spCAS9 mRNA, NAV1.7 sgRNA and NAV1.7 Non-PAM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Vertex Pharmaceuticals

US Patent
LigandPNGBDBM731575(US12269804, Compound 24)
Affinity DataKi:  3nMAssay Description:To investigate the effect of DNA-PK inhibitors on HDR gene editing rates, BECs were electroporated with spCAS9 mRNA, NAV1.7 sgRNA and NAV1.7 Non-PAM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Vertex Pharmaceuticals

US Patent
LigandPNGBDBM731574(US12269804, Compound 23)
Affinity DataKi:  3nMAssay Description:To investigate the effect of DNA-PK inhibitors on HDR gene editing rates, BECs were electroporated with spCAS9 mRNA, NAV1.7 sgRNA and NAV1.7 Non-PAM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Vertex Pharmaceuticals

US Patent
LigandPNGBDBM731556(US12269804, Compound 1)
Affinity DataKi:  3nMAssay Description:To investigate the effect of DNA-PK inhibitors on HDR gene editing rates, BECs were electroporated with spCAS9 mRNA, NAV1.7 sgRNA and NAV1.7 Non-PAM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Vertex Pharmaceuticals

US Patent
LigandPNGBDBM731571(US12269804, Compound 20)
Affinity DataKi:  3nMAssay Description:To investigate the effect of DNA-PK inhibitors on HDR gene editing rates, BECs were electroporated with spCAS9 mRNA, NAV1.7 sgRNA and NAV1.7 Non-PAM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Vertex Pharmaceuticals

US Patent
LigandPNGBDBM731570(US12269804, Compound 19)
Affinity DataKi:  4nMAssay Description:To investigate the effect of DNA-PK inhibitors on HDR gene editing rates, BECs were electroporated with spCAS9 mRNA, NAV1.7 sgRNA and NAV1.7 Non-PAM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Vertex Pharmaceuticals

US Patent
LigandPNGBDBM731579(US12269804, Compound 30)
Affinity DataKi:  4nMAssay Description:To investigate the effect of DNA-PK inhibitors on HDR gene editing rates, BECs were electroporated with spCAS9 mRNA, NAV1.7 sgRNA and NAV1.7 Non-PAM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Vertex Pharmaceuticals

US Patent
LigandPNGBDBM731592(US12269804, Compound 40)
Affinity DataKi:  4nMAssay Description:To investigate the effect of DNA-PK inhibitors on HDR gene editing rates, BECs were electroporated with spCAS9 mRNA, NAV1.7 sgRNA and NAV1.7 Non-PAM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Vertex Pharmaceuticals

US Patent
LigandPNGBDBM731581(US12269804, Compound 32)
Affinity DataKi:  5nMAssay Description:To investigate the effect of DNA-PK inhibitors on HDR gene editing rates, BECs were electroporated with spCAS9 mRNA, NAV1.7 sgRNA and NAV1.7 Non-PAM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Vertex Pharmaceuticals

US Patent
LigandPNGBDBM731580(US12269804, Compound 31)
Affinity DataKi:  5nMAssay Description:To investigate the effect of DNA-PK inhibitors on HDR gene editing rates, BECs were electroporated with spCAS9 mRNA, NAV1.7 sgRNA and NAV1.7 Non-PAM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Vertex Pharmaceuticals

US Patent
LigandPNGBDBM731577(US12269804, Compound 25)
Affinity DataKi:  5nMAssay Description:To investigate the effect of DNA-PK inhibitors on HDR gene editing rates, BECs were electroporated with spCAS9 mRNA, NAV1.7 sgRNA and NAV1.7 Non-PAM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Vertex Pharmaceuticals

US Patent
LigandPNGBDBM731558(US12269804, Compound 3)
Affinity DataKi:  5nMAssay Description:To investigate the effect of DNA-PK inhibitors on HDR gene editing rates, BECs were electroporated with spCAS9 mRNA, NAV1.7 sgRNA and NAV1.7 Non-PAM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Vertex Pharmaceuticals

US Patent
LigandPNGBDBM731572(US12269804, Compound 21)
Affinity DataKi:  6nMAssay Description:To investigate the effect of DNA-PK inhibitors on HDR gene editing rates, BECs were electroporated with spCAS9 mRNA, NAV1.7 sgRNA and NAV1.7 Non-PAM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Vertex Pharmaceuticals

US Patent
LigandPNGBDBM731562(US12269804, Compound 7)
Affinity DataKi:  8nMAssay Description:To investigate the effect of DNA-PK inhibitors on HDR gene editing rates, BECs were electroporated with spCAS9 mRNA, NAV1.7 sgRNA and NAV1.7 Non-PAM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Vertex Pharmaceuticals

US Patent
LigandPNGBDBM731573(US12269804, Compound 22)
Affinity DataKi:  8nMAssay Description:To investigate the effect of DNA-PK inhibitors on HDR gene editing rates, BECs were electroporated with spCAS9 mRNA, NAV1.7 sgRNA and NAV1.7 Non-PAM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Vertex Pharmaceuticals

US Patent
LigandPNGBDBM731566(US12269804, Compound 13)
Affinity DataKi:  15nMAssay Description:To investigate the effect of DNA-PK inhibitors on HDR gene editing rates, BECs were electroporated with spCAS9 mRNA, NAV1.7 sgRNA and NAV1.7 Non-PAM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Vertex Pharmaceuticals

US Patent
LigandPNGBDBM731563(US12269804, Compound 8)
Affinity DataKi:  15nMAssay Description:To investigate the effect of DNA-PK inhibitors on HDR gene editing rates, BECs were electroporated with spCAS9 mRNA, NAV1.7 sgRNA and NAV1.7 Non-PAM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Vertex Pharmaceuticals

US Patent
LigandPNGBDBM731565(US12269804, Compound 9)
Affinity DataKi: >4.00E+3nMAssay Description:To investigate the effect of DNA-PK inhibitors on HDR gene editing rates, BECs were electroporated with spCAS9 mRNA, NAV1.7 sgRNA and NAV1.7 Non-PAM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent